← Eichor
Condition: Paraneoplastic Neurological Syndrome Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Paraneoplastic Neurological Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Collection of Biological Samples From Patients With Rare Neurological Diseases
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT04698421Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-m
Phase N/A · 1 location(s) · ZS Associates · NCT06866483A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Disease
Phase 1 · 13 location(s) · Arcellx, Inc. · NCT06626919Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
NA · 62 location(s) · Hospices Civils de Lyon · NCT05198661Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in
EARLY_Phase 1 · 1 location(s) · Tianjin Huanhu Hospital · NCT06939166Capturing Key MG-symptoms Using Smartphone Recordings.
Phase N/A · 2 location(s) · Leiden University Medical Center · NCT06743490Liquid Biopsy in Paraneoplastic Neurological Syndromes
Phase N/A · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT07491328A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Phase 1 · 6 location(s) · Kite, A Gilead Company · NCT07304154Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06941584Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Media
Phase 1 · 1 location(s) · Tongji Hospital · NCT07526493Biomarkers in Autoimmune Disease of Nervous System
Phase N/A · 1 location(s) · Tongji Hospital · NCT06502015Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT05772611CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
EARLY_Phase 1 · 1 location(s) · Tongji Hospital · NCT07337785Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT07136844A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms
Phase 1 · 35 location(s) · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT06220201
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.